|
|
One Glenhardie Corporate Center 1275 Drummers Lane Suite 300 Wayne, PA 19087 USA phone:+1 610 975 9533 fax:+1 610 975 9556
|
|
| Symbol |
ENCO |
| Exchange |
NASDAQ |
| Founded |
0 |
| Employees |
|
|
|
| www.remedium.fi
|
|
| Research Sector |
Healthcare Services |
|
 |
| Summary Description |
| Phase I to IV clinical trials in all therapeutic areas. |
 |
| Management |
| Dr. David Ginsberg, MD, President and Chief Executive Officer; Dr. Kai E. Lindevall MD, PhD, Executive Chairman, President, International Operations Europe and Asia; Linda L. Nardone, Ph.D., RAC, Chief Operating Officer and Executive Vice President; Eeva-Kaarina Koskelo,PhD,eMBA, Vice President, Clinical Operations, Europe and Asia |
| |
|
|
|
|
|
|
|
| Keywords |
| clinical trial, vaccines, oncology, cardiology, rheumatology, endocrinology |
|
|
|
| Description |
|
Remedium is a Contract Research Organisation, delivering to customers a qualified Clinical Research framework for conducting clinical trials. |
 |
| Products / Services |
Remedium conducts Phase I to IV clinical trials in all therapeutic areas but with particular experience in the following: Vaccines, Oncology, Cardiology, Rheumatology and Endocrinology.
|
 |
 |
|
|
|
|
|
|